BSE Code: | NSE Code: | ISIN: | Sector:
Research Report Detail
|Report Date||Call||Price@Call||Target Price
|Current Status||Time Horizon|
|Closed|| Long (1Y)
Nirmal Bang maintains buy on Aurobindo Pharma
Nirmal Bang securities has maintained "buy" call on Aurobindo Pharma for a target price of Rs 920. The brokerage says 30-35 new product launches are expected in the second half of FY2017, which will boost Aurobindo Pharma's revenue going ahead.